More cases of illness linked to meningitis vaccine

[Guest guest]

So let's make it mandatory!

http://www.klfy.com/Global/story.asp?S=4732458

[Guest guest]

Why doesn't this surprise me?

Tell the victims it was for the good of the herd.

http://news./s/nm/20060406/hl_nm/meningitis_vaccine_dc_1

More cases of illness linked to meningitis vaccine Thu Apr 6, 1:48

PM ET

Three more cases of Guillain-Barre syndrome (GBS), a neurological

disorder involving temporary paralysis, have been reported in people

given the Menactra vaccine to prevent meningitis.

The additional cases bringing the total number reported to eight,

according to an article in the Morbidity and Mortality Weekly

Report, published by the Centers for Disease Control and Prevention.

Still, when the eight cases of Menactra-related GBS were compared

against the expected rates of GBS in populations in the same age

group, no significantly increased risk was seen, suggesting that the

association may have been due to chance alone.

The CDC continues to recommend Menactra for people who run a high

risk for contracting meningitis, such as first-year college students

living in dormitories, military recruits, and travelers to regions

where meningitis is epidemic.

The possible link between the vaccine and GBS first surfaced in

October 2005. At that time, five confirmed cases of the syndrome had

been reported to the Vaccine Adverse Events Reporting System. In the

present report, researchers from the CDC describe in detail two of

the three cases that occurred between October 2005 and February 2006.

The first case involved a 19-year-old man who began experiencing

numbness and weakness in his extremities, difficulty running, and

decreased dexterity 25 days after being vaccinated with Menactra.

Test results were consistent with GBS, and other possible causes of

the neurologic symptoms were ruled out. He was treated and had made

a full recovery by eight weeks after symptoms began.

The second case, which involved a 17-year-old male, was similar to

the first, but disease onset occurred just 11 days after he was

given the Menactra vaccine. Treatment resulted in a complete

recovery two weeks after he has admitted to the hospital.

SOURCE: Morbidity and Mortality Weekly Report, April 6, 2006.

Copyright © 2006 Reuters Limited. All rights reserved. Republication

or redistribution of Reuters content is expressly prohibited without

the prior written consent of Reuters. Reuters shall not be liable

for any errors or delays in the content, or for any actions taken in

reliance thereon.

Copyright © 2006 All rights reserved.

Questions or Comments

Privacy Policy -Terms of Service - Copyright/IP Policy - Ad Feedback